Chronic Periodontitis Clinical Trial
Official title:
Thyroid Insufficiency as a Modifying Factor for Chronic Periodontitis
Verified date | September 2023 |
Source | University at Buffalo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Currently, the investigators are unaware of any previous studies that have analyzed the relationship between the prevalence of thyroid disease and chronic periodontitis among adults utilizing a retrospective, cross-sectional design. This study will review approximately 2000 patient records and compare the prevalence of thyroid disease in three groups with increasing severity of chronic periodontitis.
Status | Completed |
Enrollment | 4965 |
Est. completion date | September 1, 2023 |
Est. primary completion date | September 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 35 Years and older |
Eligibility | Inclusion Criteria: - Active patient of the School of Dental Medicine, University at Buffalo. - The remaining eligibility criteria varies between the three distinct subject populations, which are noted below. All eligibility criteria is selected for by an electronic search of patient records performed by the IT Department at the School of Dental Medicine, University at Buffalo. 1. Periodontally healthy patients: 1. A treatment code of D1110 or D111 was processed at least once but excluding patients that were ever assigned a treatment code of U4990 2. A 3rd or 4th year pre-doctoral dental student provider 3. 35 years or older as of 1/1/2016 4. Patient presented to clinic between 1/1/2016-12/31/2016 2. Patients with history of advanced periodontal treatment, group 1: 1. All patients presenting to the Postgraduate Periodontics Department at UB and being seen by a periodontics resident 2. Time period between 1/1/2000-12/31/2017 3. Patients will be 35 years or older at time of initial exam 4. Patients presenting for reasons other than chronic periodontitis treatment (e.g. crown lengthening) will be labeled as such. 3. Patients with history of advanced periodontal treatment, group 2: 1. All patients treated in the faculty practice of one periodontist that remained active patients during the time period 1/1/2016-12/31-2016 2. All patients were 35 years or older at time of initial exam Duplicates within groups are eliminated. Exclusion Criteria: - inadequate data from records Note: the majority of patient records selected by the search criteria done electronically by the IT department will be included in the study, since the search criteria very closely overlaps the overall study criteria |
Country | Name | City | State |
---|---|---|---|
United States | School of Dental Medicine, University at Buffalo | Buffalo | New York |
Lead Sponsor | Collaborator |
---|---|
University at Buffalo |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Thyroid disease prevalence | The presence or absence of thyroid medication in the patient record will be used as a surrogate marker for thyroid disease presence or absence. | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | smoking history | Smoking history will be determined from the Medical Questionnaire form in the patient records. | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | diabetes disease prevalence | The Medical Questionnaire and the Medication List in the patient records will be referenced to determine the presence of diabetes. | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | Periodontal Probing Depths 5mm or greater | Number of teeth that have one or more sites that contain a 5mm or greater pocket, recorded in periodontal chart | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | Periodontal Probing Depths 6mm or greater | Number of teeth that have one or more sites that contain a 6mm or greater pocket, recorded in periodontal chart | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | Teeth | Total number of teeth, recorded in periodontal chart | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | proton pump inhibitor use | The Medication List in the patient records will be referenced to determine any history of proton pump inhibitor use. | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | Plaque Score | Percentage of tooth surfaces positive for plaque out of total tooth surfaces | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | Hormone replacement therapy | The presence or absence of hormone supplementation (birth control or hormone replacement therapy included) | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). | |
Secondary | bisphosphonate use | The Medication List in the patient records will be referenced to determine any history of bisphosphonate use. | Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A | |
Completed |
NCT02851823 -
Combined Use of Er:YAG and Nd:YAG Laser
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 |